Ciferavit D3 zur Therapie

Ciferavit D3 zur Therapie is a medicine authorised by Swissmedic under authorisation number 68496. The authorisation holder is Medius AG. The medicinal product code is Synthetic medicines and the dispensing category is B/D: The medicine has strengths in category B and in category D, so supply depends on the strength. First authorisation was granted on 24 February 2023 and the authorisation is limited until 23 February 2028. The export lists no ATC code for this medicine.

  • Dispensing category B/D
  • Authorisation number 68496
  • Synthetic medicines
Authorisation data
Authorisation number68496
NameCiferavit D3 zur Therapie
Full nameCiferavit D3 zur Therapie, Lösung zum Einnehmen
Authorisation holderMedius AG
Medicinal product codeSynthetic medicines
Dispensing categoryB/D · Mixed B and D
ATC codenot stated
First authorisation24 February 2023
Authorisation validity23 February 2028
Strengths
No.NameDispensing categoryAuthorisation date
2Ciferavit D3 zur Therapie, Lösung zum EinnehmenB/D24 February 2023
3Ciferavit D3 zur Prophylaxe, Lösung zum EinnehmenB/D24 February 2023

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
The Swissmedic export lists no pack sizes for this medicine.

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Ciferavit D3 zur Therapie authorised in Switzerland?

Yes. Ciferavit D3 zur Therapie is authorised by Swissmedic under authorisation number 68496, data as of 01 September 2026. The authorisation is limited until 23 February 2028.

Which dispensing category does Ciferavit D3 zur Therapie have?

Ciferavit D3 zur Therapie is in dispensing category B/D. The medicine has strengths in category B and in category D, so supply depends on the strength.

Who is the authorisation holder of Ciferavit D3 zur Therapie?

The authorisation holder is Medius AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com